Article
Enhancing inactivation rather than reducing activation of Nav1.7 channels by a clinically effective analgesic CNV1014802.
Acta pharmacologica Sinica - 1 Apr 2018
Zheng Yue-Ming, Wang Wan-Fu, Li Yan-Fen, Yu Yong, Gao Zhao-Bing
Abstract excerpt
The Nav1.7 channel represents a promising target for pain relief. In the recent decades, a number of Nav1.7 channel inhibitors have been developed. According to the effects on channel kinetics, these inhibitors could be divided into two major classes: reducing activation or enhancing inactivation. To date, however, only several inhibitors have moved forward into phase 2 clinical trials and most of them display a...
Topics
- Analgesics
- Animals
- CHO Cells
- Cricetulus
- Electrophysiological Phenomena
- HEK293 Cells
- Humans
- Mutagenesis, Site-Directed
- Mutation
- NAV1.7 Voltage-Gated Sodium Channel
- Phenyl Ethers
